These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30022801)

  • 1. Cardioembolic stroke: everything has changed.
    Spence JD
    Stroke Vasc Neurol; 2018 Jun; 3(2):76-83. PubMed ID: 30022801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation in patients with Embolic Stroke of Unknown Source.
    Spence JD
    Int J Stroke; 2019 Jun; 14(4):334-336. PubMed ID: 30644794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry.
    Sherwood MW; Piccini JP; Holmes DN; Pieper KS; Steinberg BA; Fonarow GC; Allen LA; Naccarelli GV; Kowey PR; Gersh BJ; Mahaffey KW; Singer DE; Ansell JE; Freeman JV; Chan PS; Reiffel JA; Blanco R; Peterson ED; Rao SV
    Circ Cardiovasc Interv; 2020 May; 13(5):e008274. PubMed ID: 32408815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs.
    Deedwania P; Huang GW
    Rev Cardiovasc Med; 2012; 13(2-3):e89-104. PubMed ID: 23160166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
    Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
    JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary approach to stroke prevention in atrial fibrillation: Risks, benefits, and new options.
    Stock J; Malm BJ
    Trends Cardiovasc Med; 2018 Oct; 28(7):469-480. PubMed ID: 29739702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design.
    Khattab AA; Windecker S; Jüni P; Hildick-Smith D; Dudek D; Andersen HR; Ibrahim R; Schuler G; Walton AS; Wahl A; Mattle HP; Meier B
    Trials; 2011 Feb; 12():56. PubMed ID: 21356042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.
    Hart RG; Pearce LA; Miller VT; Anderson DC; Rothrock JF; Albers GW; Nasco E
    Cerebrovasc Dis; 2000; 10(1):39-43. PubMed ID: 10629345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
    Gevorgyan Fleming R; Kumar P; West B; Noureddin N; Rusheen J; Aboulhosn J; Tobis JM
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):365-372. PubMed ID: 31654558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation.
    Melduni RM; Wysokinski WE; Wang Z; Gersh BJ; Asirvatham SJ; Patlolla SH; Greene EL; Oh JK; Lee HC
    Open Heart; 2020; 7(1):e001229. PubMed ID: 32518658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke].
    Donti A; Egidy Assenza G; Mariucci E
    G Ital Cardiol (Rome); 2019 Feb; 20(2):73-84. PubMed ID: 30747923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of secondary atrial fibrillation following percutaneous foramen ovale closure for cryptogenic stroke using an insertable cardiac monitor: a case report].
    Egashira S; Doijiri R; Endo H; Kimura N; Nakajima Y; Morino Y; Kikuchi T
    Rinsho Shinkeigaku; 2022 Oct; 62(10):787-792. PubMed ID: 36184419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of Hirudin plus Aspirin versus Warfarin in the secondary prevention of Cardioembolic Stroke due to Nonvalvular Atrial Fibrillation: A multicenter prospective cohort study.
    Song CG; Bi LJ; Zhao JJ; Wang X; Li W; Yang F; Jiang W
    Int J Med Sci; 2021; 18(5):1167-1178. PubMed ID: 33526977
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.